Minal M. Shah, MD| Hematology, Medical Oncology | MedStar Health
Share this profile Print this profile
Minal M. Shah

Minal M. Shah, MD
Provider is directly employed by MedStar Health

4.8 out of 5 (1744 reviews)

Specialties: Hematology, Medical Oncology, Hematology and Oncology

Languages: English, Marathi

(301) 373-6700

Clinical areas of focus

  • Bone Marrow Biopsy And Aspiration
Show More

Conditions and procedures

Conditions I treat

  • Lymphoma
  • Platelet Disorders
  • Red Blood Cell Disorders
  • Thrombosis
  • White Blood Cell Disorder
Show All Show Less

Procedures I perform

  • Ambulatory Phlebectomy
  • Bone Marrow Aspiration And Biopsy
  • Bone Marrow Biopsy And Aspiration
  • Chemotherapy Administration
  • Phlebotomy
Show All button Press enter to expand Show Less

Practice locations

Distance from Change Location Enter your Location

25500 Point Lookout Rd
Outpatient Pavillion Cancer Center
Leonardtown, MD, 20650

301-475-6070
Get Directions

miles away

Fax 301-475-6473

23415 Three Notch Rd
Ste 2051
California, MD, 20619

301-373-7800
Get Directions

miles away

Fax 301-373-6800

Education

Board Certification: American Board of Internal Medicine, Hematology

Board Certification: American Board of Internal Medicine, Medical Oncology

Fellowship: Georgetown University School of Medicine GME (2009)

Residency: MedStar Washington Hospital Center (2006)

Medical School: Lokmanya Tilak Municipal Medical College (1993)

Ratings and reviews

  • Explanations the care provider gave you about your problem or condition

    4.8
  • Extent to which the care provider listened to you

    4.8
  • Care provider’s discussion of any proposed treatment (options, risks, benefits, etc.)

    4.8
  • Provider included you in decisions

    4.8
  • Concern the care provider showed for your questions or worries

    4.8
  • Likelihood of recommending this care provider to others

    4.8
  • Jun 23, 2026

    Dr. Minal Shah is very professional very knowledgeable very kind and shows interest in my well-being

  • Jun 18, 2026

    Very Good

  • Jun 11, 2026

    Good